Department of Neurology, University of Duisburg-Essen, Essen, Germany.
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):869-73. doi: 10.1136/jnnp.2009.192153.
Cervical artery dissection (CAD) accounts for 10-20% of all strokes in young adults, but no randomised controlled trial has investigated the best secondary prevention after ischaemic stroke or transient ischaemic attack (TIA). Because only small numbers of patient with CAD have been prospectively documented and followed up, the authors aimed to investigate the prognosis under various prevention regimens.
30 German departments of neurology with acute stroke units prospectively documented 250 patients with acute ischaemic stroke or TIA due to CAD. A central follow-up (median 31 months) assessed recurrent stroke, recurrent CAD and death in 198 patients.
CAD was found more often in the carotid arteries (52.0%) than in the vertebral arteries (46.8%). Thirteen patients (5.2%, CI 3.1% to 8.6%) suffered a recurrent stroke during the acute hospital stay. The rate of recurrent CAD during the first year was 1.7% (95% CI 0.3% to 3.6%). The cumulative recurrent stroke rate during the first year was 10.7% (95% CI 6.5% to 14.9%) and 14.0% (95% CI 8.9% to 19.1%) over 3 years. After discharge, the rate of recurrent stroke up to 6 months in patients treated with anticoagulants was 2.0% (95% CI 0.6% to 7.1%) and in those treated with antiplatelets 16.7% (95% CI 5.8% to 39.2%), which was statistically significant (HR 0.11; CI 0.02 to 0.69, p=0.02).
This observational study confirms a high risk of early recurrent stroke following acute IS or TIA due to CAD. Whether anticoagulation provides any benefit over antiplatelets needs to be investigated in a randomised controlled trial.
颈内动脉夹层(CAD)占青年成年人所有中风的 10-20%,但尚无随机对照试验研究缺血性中风或短暂性脑缺血发作(TIA)后的最佳二级预防。由于只有少数 CAD 患者被前瞻性记录和随访,作者旨在研究各种预防方案下的预后。
30 个德国神经病学部门的急性中风病房前瞻性地记录了 250 例因 CAD 导致急性缺血性中风或 TIA 的患者。中央随访(中位数 31 个月)评估了 198 例患者的复发性中风、复发性 CAD 和死亡。
CAD 更常见于颈动脉(52.0%)而非椎动脉(46.8%)。13 例(5.2%,95%CI3.1%至 8.6%)在急性住院期间发生复发性中风。第一年复发性 CAD 的发生率为 1.7%(95%CI0.3%至 3.6%)。第一年的累积复发性中风率为 10.7%(95%CI6.5%至 14.9%),3 年内为 14.0%(95%CI8.9%至 19.1%)。出院后,接受抗凝治疗的患者 6 个月内复发性中风的发生率为 2.0%(95%CI0.6%至 7.1%),接受抗血小板治疗的患者为 16.7%(95%CI5.8%至 39.2%),具有统计学意义(HR0.11;95%CI0.02 至 0.69,p=0.02)。
这项观察性研究证实,急性 IS 或 TIA 后因 CAD 导致的早期复发性中风风险较高。抗凝治疗是否优于抗血小板治疗需要在随机对照试验中进行研究。